April 3, 2009
 
The HIV/AIDS eNews is published by the British Columbia Persons With AIDS Society. This publication is a compilation of various articles collected from numerous news sources. Opinions and information expressed are those of the individual authors and not necessarily those of the Society.
WHAT'S  NEW  AT  THE  BCPWA

AccolAIDS 2009

Join us for the 8th annual AccolAIDS Award Gala and Auction. Hosted by Symone, Vancouver's First Lady of Glam.

When: Sunday April 19th, 6PM-10PM

Where: Pacific Ballroom at the Fairmont Hotel, Vancouver.

Tickets $150 each or $1200 for a table of 8.

Click here for more info.


BC's Big Opt Out


BC’s Big Opt Out urges British Columbians to protect their right to privacy by refusing their personal health information be subject to eHealth, the BC Government’s new system of integrated electronic health records.

Visit their website www.bcoptout.ca to learn more about eHealth and what you can do about it.


VOLUNTEER RECEPTION

BCPWA invites our volunteers to the South Pacific: A Night in the Tropics! This year's volunteer appreciation party is all about grass skirts, songs and sarongs.

When: 6-9.30pm, Thursday April 30
Where: Holiday Inn & Suites (1110 Howe at Helmcken)
Tickets: $10 deposit for volunteers, $25 flat-rate for friends of volunteers.

For more information, contact Marc at 604.893.2298 or marcs@bcpwa.org

aidsday
calendar

WEDNESDAY NIGHT SUPPORT GROUP

The Wednesday evening group welcomes people living with HIV disease, people who are co-infected with Hepatitis C, as well as family, friends, medical or social supports of group members. The group focuses on mutual support, empowerment, and information exchange.

Date: Every Wednesday Evening
Time: 7:00pm - 9:00pm
Location: The Lounge - 2nd Floor
Address:1107 Seymour Street, Vancouver

aidsday
For more info, click here, or call 604.893.2259.

HEALING RETREAT

Healing retreats for HIV-positive men and women. Join HIV-positive people from all walks of life. Meet new friends and learn more about yourself.

Date: June 26 - 29, 2009 and September 4 - 7, 2009
Location: Loon Lake [ Map ]
Registration: Register at reception

To book an interview:
Phone: 604.893.2200
Toll Free: 1.800.994.2437 ext. 200

aidsday

For more info, click here.


Do You Need Better Access to Information on HIV/AIDS Treatment?

Then participate in a survey!

You can help BCPWA by participating in a research project to assess the changing treatment information needs of HIV-positive people in BC. The research examines the experiences that HIV-positive people have with access to HIV/AIDS treatment information and the quality of these experiences.

To access the questionnaire, go to:
http://infopoll.net/live/surveys/s33258.htm


Some Changes and Updates

INCOME TAX RETURNS

February 25, 2009 through April 15th 2009. Sign up at Front Desk or call 604-893-2200.

taxreturn

POLLI & ESTHER'S CLOSET

Now by appointment only.

Members are allowed one visit per month.


FitOne - An Introduction to Active Living

Designed for individuals seeking a more active lifestyle, FitOne aims to educate participants about the beneficial effects of exercise on HIV disease while creating a mutually supportive and motivating environment.

Intended for all fitness levels, a certified kinesiologist will assess and design programs suited for individual needs. Yoga mats and exercise equipement provided. Comfortable cloths and exercise shoes recommended. Beginners welcome.

Activities may include group walks, running clinics, and beginner's yoga.

fit1

Weekly sessions begin Wednesday, February 25, 2009 from 3 – 4pm in the BCPWA Training Room

For more information, please contact elginl@bcpwa.org or call 604.893-2225. Limited number of participants. Register now.


newAmBigYouUs

Are you HIV+ and Trans? Join us at AmBigYouUs, a monthly mingling and networking event specifically for the HIV+ Trans community.

Where: BCPWA's Training Room (1st Floor)

When: First Wednesday of the month, 6-8pm

For more information, please call 604.893.2258

aidsday
calendar

SPIRITUAL WORKSHOP

Non-denominational, supportive, unique and fun.

Join other HIV+ men and women, lakeside at the Bethlehem Retreat Centre on Vancouver Island for a 3-night/ 4 day workshop devoted to personal spirituality. A provocative, progressive workshop created on the teachings of Mathew Fox. People come away renewed with a sense of hope, a feeling of global community and a boost to their self-esteem.

spiritposter

Workshop designed and facilitated by United Church Ministers, Rev. Tim Stevenson, and spouse Rev. Gary Paterson, Minister St. Andrew's Wesley United Church. Taking time to laugh and to listen, their knowledge and kindness enhances learning and garners trust.

Organized by BCPWA Retreat Team.
Lodging and meal hosted by the Benedictine Sisters.
Transportation provided.

Spaces go quickly.

Interviews March 2-April 10, 2009.
Register for an interview 604.893.2200 or 1.800.994.2437.


LEND YOUR VOICE

Survey on Employment Issues for People Living with HIV/AIDS

People living with HIV are invited to participate in an online survey on HIV and employment in Canada. The purpose of this survey is to learn more about the education, training, employment and health needs of people living with HIV. Our ultimate goal is a national network that will provide employment support, information and advocacy opportunities for people living with HIV whether in or out of the workforce. Your responses to the survey will inform us on the employment-related issues that matter to you most.

The survey is available electronically and will take approximately 25 minutes to complete. You will be able to save survey responses and then submit the final version at a later date. If you would like to request a hardcopy of the survey please send your contact information to the address below.

You do not have to give personal information and we do not plan to publish personal information. If this plan changes, we will only do so with your agreement. You have the right to opt out of any question(s) at any point throughout the survey. You may choose to provide us with contact information if you would like to be kept updated on the progress of this project.

The link to the survey is provided below. The survey will be open for responses through Friday, March 13. This opportunity is unique to people with HIV. We look forward to your response to the survey.

http://www.surveymonkey.com/s.aspx?sm=BxPMtNFSCtrk5n1CZTiWPQ_3d_3d

  more... []

LOCAL  &  NATIONAL  eNEWS

Victoria man gets 10 years in prison in HIV sex-assault case
Musician failed to tell four women he was HIV positive; one has been infected

March 31, 2009

A member of a popular Victoria marimba band has been sentenced to 10 years less three days for having unprotected sex with four Greater Victoria women without telling them he was HIV positive.

On March 2, Charles Kokanai Mzite, 37, was convicted of four counts of aggravated sexual assault between May 2001 and November 2005. Today, B.C. Supreme Court Justice Robert Johnston told Mzite he had committed offences that could only be described as “profoundly selfish.”

“You infected one woman and exposed three others to very serious risk to satisfy your own needs for intimacy and sexual gratification,” said Johnston.

“Each of the complaints would have refused to have sexual intercourse with Mr. Mzite if she’d known he was HIV positive. Each of the cases occurred in the context of a relationship. ... Each of the victims felt safe because he denied he was HIV positive.”

Johnston sentenced Mzite to four years for the woman he infected with HIV, the virus that causes AIDS, and two years less a day for each of his other three victims. The sentences are to be served consecutively.

Mzite, who was been in custody since September 2007, was credited with 37.5 months time served. This means he must serve a further six years and 10 months in prison.

Mzite, a dancer and musician who used to perform with the Jambanja group on the streets of downtown Victoria, must also comply with the National Sex Offender Registry and provide a DNA sample. The judge did not impose a weapons prohibition as requested by Crown prosecutor Nils Jensen.

Defence lawyer Martin Allen indicated to the court that his client might appeal his conviction.

Mzite, who appeared in court with his head shorn, chose not to address the court before Johnston passed sentence upon him. He sat impassive, slumped in a corner of the prisoners’ dock. None of his victims were present in the courtroom.

Johnston acknowledged the sentence will affect Mzite’s immigration status. Mzite came to Canada from Zimbabwe in 2001. He has been a convention refugee since his application was accepted in 2001 and is a protected person under the Immigration and Refugee Act.

“I have evidence, that as a result of these convictions, Mr. Mzite will, in all likelihood, be ordered deported from Canada,” said Johnston.

Although, with a sentence of four years, Mzite has lost his right of appeal to the Immigration Appeal Board, he will not be deported automatically, said Johnston. As a protected person, he has a right to appeal directly to the Minister of Citizenship and Immigration.

“The minister will be called upon to balance the risk to the Canadian public if Mr. Mzite is allowed to remain in Canada against the risk Mr. Mzite will be persecuted, tortured or subject to cruel or unusual punishment if he is removed to Zimbabwe.”

Johnston also noted Mzite’s health would be at risk if he is deported. Treatment for HIV is much more advanced in Canada than in Zimbabwe.

“I do conclude that without the kind of treatment available here, Mr. Mzite’s infection will almost inevitably progress much faster and lead to his death much sooner. But Mr. Mzite will have an opportunity to be heard in the deportation process,” said Johnston.

Johnston noted that Mzite applied himself well in custody, taking courses in respectful relationships, substance abuse management and peer education to help in harm reduction.

By Louise Dickson, Times Colonist
  more... []

Calgary Catholic teachers drop charity in condom protest
Calgary Catholic teachers have cancelled a fundraiser for AIDS relief in Africa after a local bishop spoke out against a prominent Canadian and his foundation’s AIDS prevention programs, which include promoting condoms.

March 28, 2009

Calgary - Calgary Catholic teachers have cancelled a fundraiser for AIDS relief in Africa after a local bishop spoke out against a prominent Canadian and his foundation’s AIDS prevention programs, which include promoting condoms.

But with the Stephen Lewis Foundation donating hundreds of thousands of dollars annually to several church-run AIDS programs in Africa, Lewis said that the bishop’s efforts to “excommunicate” the charity are only going to hurt Catholics there.

“The bishop didn’t stop to think, when you say to teachers you can’t raise money for a foundation that is directly supporting Catholic projects in Africa, then you are discriminating against those projects. You are harming your own people,” Lewis said.

Teachers at the Calgary Catholic School District have been passing the hat around among themselves during Lent for the past five years to raise money for the Stephen Lewis Foundation’s AIDS work in sub-Saharan Africa.

Last year, teachers raised $45,000 through personal and matching donations, said Calgary Catholic Teachers’ Association president David Cracknell.

But in December, a parishioner approached Calgary Bishop Fred Henry with questions about teachers raising funds for an organization that uses condoms in its AIDS prevention programs, he said.

Henry met with Cracknell to discuss the issue, then sent a letter to the teachers’ association encouraging members to focus their fundraising efforts on other organizations in Africa.

“For me, it’s been a difficult issue,” said Cracknell.

“I understand the commitment our teachers have toward helping people in Africa with AIDS. I understand the fact Stephen Lewis is a very prominent Canadian, and people are very committed to his charity. But I also understand the bishop is our moral guide.”

In a letter to the editor of the Calgary Herald, Henry said the Christian virtues of chastity, abstinence and fidelity are “the most effective means of primary HIV prevention,” and should not be pushed aside as valid prevention options in favour of passing out condoms.

When asked about his opposition to the Stephen Lewis Foundation, Henry said teachers do have other options in supporting AIDS charity efforts in Africa.

“If you have two businesses or organizations, one that doesn’t support your values and mission statement and another that does, which one are you going to support? I think that the answer is obvious,” Henry told the newspaper in an e-mail.

The Calgary Catholic Teachers’ Association is evaluating whether it will organize fundraisers for Lewis’s foundation in future.

By Sarah McGinnis, www.theherald.canwest.com
  more... []

Saskatchewan. to hire more workers to deal with HIV cases
Saskatchewan says it will hire up to 15 new workers over the next several years to deal with what medical officials are calling an alarming increase in HIV cases.

March 28, 2009

Regina -- Saskatchewan says it will hire up to 15 new workers over the next several years to deal with what medical officials are calling an alarming increase in HIV cases.

The province recorded 170 new cases last year - a 40 per cent increase - which is about twice the national average. Dr. Moira McKinnon, the province's chief medical health officer, says more than half of the cases are women under the age of 30 and most of the cases involve intravenous drug use.

About 65 per cent of the people are aboriginal, including two girls who are under 15. Seven babies were also born HIV positive.

"It is alarming," she says. "We're having women turn up who have had no pre-natal care and delivering babies and they're HIV positive. These people aren't accessing the health system."

McKinnon says most of the new cases involve people who live in poor urban areas.

"Most of the cases are reported in Saskatoon, Regina and Prince Albert, but because the population is transient, it may be that they also have community homes and they're only disclosing their urban addresses. So we have some work to do in that area."

She says the province is also looking at bolstering testing and early treatment of HIV, the virus that leads to AIDS.

"Diagnosing people early and getting them on treatment is one of the most effective ways of preventing transmission," she says.

The Canadian Press, http://www.ctv.ca
  more... []

Official wants to see anonymous HIV/AIDS testing
Anonymous HIV/AIDS testing is needed on P.E.I., according to Mark Hanlon. And it’s something the AIDS P.E.I. executive director plans to push government for. “Right now we are the only province in Canada, yet again, that doesn’t have anonymous testing, which is a big problem,” said Hanlon. “If you don’t provide anonymous testing people are wary of getting tested.”

March 30, 2009

Summerside, PEI  – Anonymous HIV/AIDS testing is needed on P.E.I., according to Mark Hanlon. And it’s something the AIDS P.E.I. executive director plans to push government for.

“Right now we are the only province in Canada, yet again, that doesn’t have anonymous testing, which is a big problem,” said Hanlon. “If you don’t provide anonymous testing people are wary of getting tested.”

Islanders wanting to be tested for HIV/AIDS do so through their doctor via nominal testing, where their name is on the request, or non-nominal testing.

“People can go to their doctor, their doctor knows who they are and there’s a code submitted to government,” Hanlon said, explaining non-nominal testing.

With anonymous testing, a subject doesn’t provide their name or other personal information. Only the person tested knows they were tested and is privy to their results.

Hanlon said AIDS P.E.I. could potentially be a test site.

“They could go in on a Monday, get tested, and on Friday, they just come in, give a number. We have the numbers for the tests and they get the test results back,” he added. “If they want to come back and talk to us about a positive result or they want to talk about a negative result and how they can avoid problems then we can do that.”

But providing anonymous testing would require government’s help.

“We need somebody on site. It doesn’t mean they have to give us any money. They could provide a nurse,” said Hanlon. “One-day-a-week testing and having the nurse come back later in the week to distribute the results would be great. That way there’s no face-to-face contact with other health professionals besides that nurse.”

The Province currently isn’t looking at introducing anonymous testing.

“We have not had a request from anyone to do it anonymously or a proposal from anybody who would do it. We would take it on and look at it if a request came,” said Dr. Lamont Sweet, deputy chief health officer. “It does require that a physician be responsible for requesting the test. So, if a physician wanted to apply to do that anywhere, then we would have to look at that.”

Since 1985 46 people have registered as having HIV or AIDS.

Hanlon said AIDS P.E.I.’s goal is to eventually provide anonymous testing “in each corner of the province.”

“We’ve kind of had it on our radar for awhile,” he added. “It certainly would be a fantastic thing.”

Four types of HIV testing in Canada:

Nominal/name-based HIV testing
-Carried out at clinics and office of a health-care provider.
-Person ordering test knows identify of the person being tested.
-Test is ordered using the name of person being tested.
-Collection of patient information including age, gender, city of residence.
-If results are positive, person tested is legally obligated to notify public health officials of the positive test result.
Non-nominal/non-identifying HIV testing
-Similar to nominal/name-based testing on all points except the HIV test is ordered using a code or initials of the person being tested.
Anonymous testing
-Usually available at specialized clinics, organized and supported by public health departments and by some health-care providers.
-Person ordering test doesn’t know identity of person being tested.
-Carried out using a code. Person ordering test and lab carrying it out don’t know who the code belongs to; only person being tested knows.
-Information such as age, gender and person’s ethnicity may be collected.
-Test results are not recorded on the health care record of person tested.
Rapid testing
Administered by health professionals at specific clinics or doctors’ offices. Results are available on-site within minutes. Currently available in limited number of locations.

By Nancy MacPhee, http://www.journalpioneer.com
  more... []

Patients feeling abandoned, AIDS committee says
Patients with HIV/AIDS are not getting the special care they require, the Newfoundland and Labrador AIDS Committee says.

March 31, 2009

Patients with HIV/AIDS are not getting the special care they require, the Newfoundland and Labrador AIDS Committee says.

The only infectious disease specialist in the province recently moved away, and out-of-province physicians now provide sporadic services every five weeks.

Chris Pickard, executive director of the AIDS committee, said a regular clinic has been suspended because its nurse-practitioner is on leave until at least mid-April, and a social worker assigned to it is available for just over a day each week.

He said people living with HIV/AIDS are feeling abandoned.

"We're not about trying to create panic, but I think we have to make sure that this kind of goes to the highest level, that this is a critical health issue," Pickard told CBC News Tuesday.

"People right now don't know what to do. They're calling into the clinic, leaving a message, and hopefully, someone is getting back to them," said Pickard, adding patients are optimistic that a new infectious diseases specialist will soon be hired.

In a statement, Eastern Health said Tuesday it hopes to resume its clinics by late April.

The clinics will continue until August, or until a new infectious disease specialist is on duty. Until then, internal medicine specialists will provide consultations with patients.

"Eastern Health would like to emphasize that these are interim contingency measures, designed to ensure care for our infectious disease patients until a full-time specialist is in place," the authority said.

Eastern Health said it hoped to finish negotiations with a new specialist "in the very near future."

Last week, patients and their supporters held a rally at Confederation Building to raise awareness about the lack of regular treatment.

http://www.cbc.ca
  more... []

On reserve or off, AIDS a disease of poverty
"A couple of years ago, I did a documentary on AIDS in the aboriginal community in Saskatchewan. I called it The Hidden Plague. Today, it's not so hidden. It's a crisis."

March 30, 2009

A couple of years ago, I did a documentary on AIDS in the aboriginal community in Saskatchewan. I called it The Hidden Plague. Today, it's not so hidden. It's a crisis.

When I first looked at HIV/AIDS in the province, the problem was serious and experts expected it to worsen. Saskatchewan now leads Canada in new cases of HIV per capita, with double the national rate.

Last year, Saskatchewan had 174 new cases of HIV. This was up 40 per cent from the previous year, when there were 124 new cases. The number is expected to rise this year and next.

Even more alarming is the fact that one-quarter of the HIV-positive babies born in Canada are in Saskatchewan. Of the 23 HIV-positive babies born across Canada last year, seven were in this province.

These may seem like small numbers when we look at a provincial population of about a million people, but the incidence of AIDS is located in pockets and includes a disproportionate number of aboriginal people.

A virulent new strain of HIV has emerged that does not respond well to existing medication. AIDS is a long-term disease that can take years to take hold and can be controlled for years after that.

But this new strain takes about two years to move from an HIV infection to full blown AIDS. This means that in the future we will see increased costs and stresses on the medical system.

So what is the reason behind this epidemic? There is a shallow answer and a deeper one.

First, HIV/AIDS most often is a product of a high-risk lifestyle. Intravenous drug users and sex trade workers are the groups most at risk.

The drug of choice in Saskatchewan for many people is injection cocaine, and 60 per cent of the new cases were associated with injection. This addiction can lead up to 20 needles per day.

Drug addiction and prostitution go hand in hand. Most sex trade workers are on the street because of a drug addiction. Many are slaves to their pimp, who keeps them high in return for cash. HIV-positive sex trade workers pass it on to the johns, who spread it throughout the population.

This is reflected in the fact that almost one-third of the new HIV cases are women under age 29, with the youngest 15 years old. Many of these women are aboriginal.

The next question is: Why are aboriginal people most likely to be in a high-risk lifestyle?

Poverty plays a huge part. Lack of opportunity, poor education and related depression all play a role. But social issues are a symptom of a greater problem.

The root of the problem lies in history and societal factors.

For most of the 20th century, generations of our people were placed in residential schools.

This experience sapped our self-esteem, destroyed our social system and ruined our parenting skills. The results are still with us.

Since this is a crisis on several levels, it needs to be attacked the same way. We need more education about the dangers of intravenous drug use; where the problem already exists, we need to practise harm reduction. This means more needle exchange programs and the establishment of safe injection sites.

A lot of people see harm reduction as a stamp of approval or encouragement, but I see it as facing reality and treating people with respect.

Addicts are now treated as criminals. We need to move beyond a revenge mentality and treat addiction as a health issue.

The same goes for AIDS, which many people consider a less worthy disease because of how it is spread. In the end, it's a fatal disease just like many others.

At one time, AIDS was seen as a disease of gay men. Now it's a disease of poverty.

It has taken root in the inner cities in the United States, the slums of Asia and villages in Africa. It has also found fertile ground in the aboriginal slums of Western Canada.

The growing incidence of AIDS is moving to a crisis and there is no end in sight. The root problems that lead to drug use and prostitution continue to exist. Our people are living in grinding poverty and its damage is evident.

Until governments and individual address the root causes, there will be no letup in the AIDS crisis.

By Doug Cuthand, Saskatoon StarPhoenix, The Victoria Times Colonist
  more... []

INTERNATIONAL NEWS

1. Research May Support Pope's Comments Against Condom Use in Africa, Opinion Piece Says
Pope Benedict XVI "set off a firestorm of protest" earlier this month when he commented that condom distribution "isn't helping, and may be worsening" the spread of HIV/AIDS in Africa, but "in truth, current empirical evidence supports him," Edward Green, a senior research scientist at the Harvard School of Public Health, writes in a Washington Post opinion piece.
2. Medical Journal Slams Pope’s Condom Lie
“The Catholic Church’s ethical opposition to birth control and support of marital fidelity and abstinence in HIV prevention” are “well known,” states The Lancet’s editorial, which some criticized as “virulent.” “But, by saying that condoms exacerbate the problem of HIV, the pope has publicly distorted scientific evidence to promote Catholic doctrine on this issue,” said the editorial.

1. Research May Support Pope's Comments Against Condom Use in Africa, Opinion Piece Says

March 30, 2009

Pope Benedict XVI "set off a firestorm of protest" earlier this month when he commented that condom distribution "isn't helping, and may be worsening" the spread of HIV/AIDS in Africa, but "in truth, current empirical evidence supports him," Edward Green, a senior research scientist at the Harvard School of Public Health, writes in a Washington Post opinion piece. The condom has become a "symbol of freedom and -- along with contraception -- female emancipation," Green writes, adding that those who "question condom orthodoxy are accused of being against these causes." Members of the HIV/AIDS and family planning communities "take terrible professional risks if we side with the pope on a divisive topic such as this," Green writes, noting that his comments "are only about the questions of condoms working to stem the spread of AIDS in Africa's generalized epidemics -- nowhere else."

According to Green, several research articles published in peer-reviewed journals such as the Lancet, Science and BMJ "have confirmed that condoms have not worked as a primary intervention in the population-wide epidemics of Africa." He adds that condom promotion "has worked" in countries such as Cambodia and Thailand, where HIV is transmitted primarily through commercial sex. "In theory, condom promotions ought to work everywhere," Green writes, adding that this is "not what the research in Africa shows."

Green writes that "people think they're made safe by using condoms at least some of the time" and they "actually engage in riskier sex." In addition, many people in Africa rarely use condoms in stable relationships "because doing so would imply a lack of trust," Green continues, adding that it is "those ongoing relationships that drive Africa's worst epidemics" where most HIV cases occur in general populations rather than high-risk groups like commercial sex workers, men who have sex with men or injection drug users. "And in significant proportions of African populations, people have two or more regular sex partners who overlap in time," creating an "invisible web of relationships through which HIV/AIDS spreads," Green writes. What has proven effective in Africa are "[s]trategies that break up these multiple and concurrent sexual networks -- or, in plain language, faithful mutual monogamy or at least reduction in numbers of partners, especially concurrent ones," Green writes, adding, "'Closed' or faithful polygamy can work as well."

Green says that he is "not anti-condom," adding, "All people should have full access to condoms, and condoms should always be a backup strategy for those who will not or cannot remain in a mutually faithful relationship." In addition, "liberals and conservatives agree that condoms cannot address challenges that remain critical in Africa such as cross-generational sex, gender inequality, and an end to domestic violence, rape and sexual coercion," Green continues, concluding, "Surely it's time to start providing more evidence-based AIDS prevention in Africa" (Green, Washington Post, 3/29).

http://www.kaisernetwork.org

2. Medical Journal Slams Pope’s Condom Lie

March 29, 2009

pope
The Lancet medical journal today urged Pope Benedict XVI
to retract or correct the public record regarding his comments about the utility of condoms in fighting HIV in Africa.

RELATED ARTICLES
More Condom Lies From the Pope
France, Germany, U.N. Denounce Pope’s Comments
Vatican Defends Pope’s Condom Lie

During the pope’s first trip to Africa earlier this month, he said HIV is a “tragedy that cannot be overcome by money alone, that cannot be overcome through the distribution of condoms, which can even increase the problem.”

“The Catholic Church’s ethical opposition to birth control and support of marital fidelity and abstinence in HIV prevention” are “well known,” states The Lancet’s editorial, which some criticized as “virulent.” “But, by saying that condoms exacerbate the problem of HIV, the pope has publicly distorted scientific evidence to promote Catholic doctrine on this issue,” said the editorial.

“The governments of Germany, France, and Belgium released statements criticizing the pope’s views,” as did aid agencies, The Lancet said. “The Joint United Nations Programme on HIV/AIDS, the U.N. Population Fund, and the World Health Organization released an updated position statement on HIV prevention and condoms, which said that “the male latex condom is the single most efficient, available technology to reduce the sexual transmission of HIV.”

“Whether the pope’s error was due to ignorance or a deliberate attempt to manipulate science to support Catholic ideology is unclear,” said the editorial. “When any influential person, be it a religious or political figure, makes a false scientific statement that could be devastating to the health of millions of people, they should retract or correct the public record. Anything less from Pope Benedict would be an immense disservice to the public and health advocates, including many thousands of Catholics, who work tirelessly to try and prevent the spread of HIV and AIDS worldwide.”

The editorial is titled “Redemption for the Pope?”

http://www.hivplusmag.com

  more... []

Newly Created Institute 'Rare Bit of Good News' In HIV/AIDS Vaccine Efforts, Editorial Says
The Providence Journal says that "[p]hilanthropists everywhere are cutting back on or suspending charitable contributions," but a 2007 visit to South Africa "convinced [Ragon] there was no time to waste." Ragon's "inspiring example may encourage others leery of giving."

March 30, 2009

Although former President George W. Bush "made an ambitious new commitment to the global fight against AIDS," and Congress in 2008 "authorized billions in new spending," lawmakers and philanthropists "will retreat" as the current economic recession continues, a Providence Journal editorial says. So it "comes as a rare bit of good news" that Phillip Ragon -- founder of the software company InterSystems Corp. -- is "giving $100 million of his own to the quest for an AIDS vaccine," the Journal says. Ragon "will allocate his gift in $10 million annual installments over 10 years" to the newly formed Ragon Institute -- a collaboration between Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University -- the Journal continues, adding that the three groups will "join in an effort to find new approaches" to an HIV/AIDS vaccine.

A vaccine for HIV/AIDS "has been the holy grail of AIDS research" but has proven difficult to find because the disease "has shown an uncanny ability to alter its makeup and elude destruction," the editorial says. The Ragon Institute aims "to find new ways of deploying the immune system against a variety of diseases, not just AIDS," the Journal writes, adding that the "hope is that, for example, MIT engineers can lend new perspectives to the medical doctors, biologists and others who have already spent years tilling this hard soil." The Journal says that "[p]hilanthropists everywhere are cutting back on or suspending charitable contributions," but a 2007 visit to South Africa "convinced [Ragon] there was no time to waste." Ragon's "inspiring example may encourage others leery of giving. May the Ragon Institute succeed," the editorial concludes (Providence Journal, 3/27).

http://www.kaisernetwork.org
  more... []

Dying, and Alone, in Myanmar
The most heartbreaking moment for doctors and nurses treating people with HIV/AIDS in Myanmar is the arrival of a new patient. Running short of funds and medications, clinics have started turning dying people away.

March 31, 2009

myanmar
International Herald Tribune

A 49-year-old man in the advanced stages of H.I.V. has not told friends about his situation because of the social stigma attached to the disease. "The worst thing for me is the loneliness," he said. Two weeks after this photograph was taken, he died. More Photos >

Bangkok - The most heartbreaking moment for doctors and nurses treating people with HIV/AIDS in Myanmar is the arrival of a new patient. Running short of funds and medications, clinics have started turning dying people away.

Multimedia


“They continue to knock on our doors, even though we can’t take in most of them,” said Joe Belliveau, operations manager of the international aid group Médecins Sans Frontières.

The 23 clinics run by the group, also known as Doctors Without Borders, are the primary dispensers in Myanmar of the antiretroviral drugs that can prolong the lives of those infected with HIV., the virus that leads to AIDS. So most of the people it cannot treat are likely to die.

The people of Myanmar, a country that seems to have been marked for suffering, receive little foreign assistance — the country ranks among the lowest per capita for such aid in the world. The same is true for assistance for people with HIV/AIDS.

Médecins Sans Frontières estimates that 240,000 people are currently infected with H.I.V. in Myanmar and that 76,000 are in urgent need of antiretroviral drugs. Every year, about 25,000 people with the virus die.

The group’s clinics have been providing 11,000 people with the antiretroviral drugs that keep them alive. The longer they live, the more treatment they need. The group says it is unable to increase its budget there without taking money away from people in need elsewhere.

Last year it made the difficult decision to stop accepting any new patients in order to continue treating the old ones. It has opened its doors a little bit this year, accepting 3,000 new patients, still a fraction of those in need.

“When we stopped last July it was devastating for the staff,“ Belliveau said. “They couldn’t even treat the ones dying on their doorsteps.”

This year, the United Nations-backed Global Fund To Fight AIDS, Tuberculosis and Malaria has applied for government permits to bring antiretroviral drugs into Myanmar, and the number of people receiving treatment is likely to rise.

But that will only be one step. Fewer than 20 percent of those who need the drugs receive them, either from international groups or, in very small amounts, from the government, Médecins Sans Frontières said in a report released in November.

When a photographer visited a clinic a few months ago, he found anguish and fatalism among the people who had not received the drugs.

“I can only live longer if I have ART,” said one 28-year-old woman, referring to the antiretroviral treatment she needs. “Most of the money and possessions I had are already gone. My family sends me food from the village, but they cannot support my treatment. If I get ART I will be able to live, if not, I will die.”

In one room the photographer found a 49-year-old man, gaunt and weak, sitting on the side of a bed. He had no family, and because of the stigma of the disease he was ashamed to tell his friends or co-workers about it.

“The worst thing for me is the loneliness,” he said.Two weeks after his picture was taken, he was dead.

http://global.nytimes.com/
  more... []

STUDIES  & TREATMENT  eNEWS

Researchers boost immune system against cancers, HIV/AIDS with spirulina
Extracts of a local lake-weed, spirulina, have shown huge potentials in treating cancers, Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and malnutrition by boosting the immune system.

March 26, 2009

Extracts of a local lake-weed, spirulina, have shown huge potentials in treating cancers, Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and malnutrition by boosting the immune system. CHUKWUMA MUANYA reports.

THEY float on water. They are blue-green filamentous algae. Blue-green algae are aquatic plants that manufacture their own food. They grow in abundance on Lake Chad. Though often weeded out, recent studies have found the algae, spirulina, useful in treating cancers and Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), as well as boosting food production and immune system.

Spirulina are common articles of trade on the streets of Maiduguri, Borno State. Its use from Lake Chad dates as far back as the 9th century Kanem Empire. It is dried into cakes called Dih�, which are used to make broths for meals, and also sold in markets. The Spirulina is harvested from small lakes and ponds around Lake Chad.

It was reported that in 1976, an American, Larry Switzer, proposed to the Nigerian Government to use oil money to finance farms along the shores of Lake Chad to feed the country's growing urban masses. But the novelty of algae, lack of interest in food production, and a political coup doomed this plan. The lesson learnt by Switzer was to develop the technology and a consumer market in the United States first, and then apply it to the Third World.

Undeterred, Switzer later founded Proteus Corporation and the Earthrise Company, which built the first spirulina farm in California, United States, the forerunner to Earthrise Farms. Earthrise introduced spirulina in 1979.

A study reported in Nutrition and Cancer that was conducted among tobacco chewers in India reported a complete regression of pre-cancerous mouth lesions in 45 per cent of subjects who were given extracts of spirulina for 12 months. This was the first human study using spirulina as a cancer therapy.

The United Nations World Health Organisation (WHO) in Geneva has confirmed: "Spirulina represents an interesting food for multiple reasons, and it is able to be administered to children without any risk. We at WHO consider it a very suitable food."

According to a scientific review from Latin America, spirulina has a vast array of beneficial properties. It has been shown to be effective in the treatment of allergies, anemia, cancer, high cholesterol, elevated blood sugar, viral infections, inflammatory conditions, liver damage, immuno -deficiency, cardiovascular diseases, and other conditions.

Mark Stengler in his book, "A Natural Physician's Healing Therapies", wrote: "More than 100 published scientific references help support the case for the health benefits of spirulina. Some studies demonstrate that spirulina seems to possess anticancer effects and antiviral properties. Also, animal studies show that it is a powerful tonic for the immune system."

Donald R. Yance Jr. in his book, "Herbal Medicine Healing Cancer" wrote: "Spirulina's pure protein, which arrives within the context of massive amounts of beta-carotene, chlorophyll, fatty-acid -gamma-linolenic acid (GLA), and other nutrients, is especially helpful to those who are overweight, diabetic, hypoglycemic, or suffering from cancer, arthritis, or other degenerative diseases. "

An advocate of natural medicine and a Consultant Homeopath at the Global Foundation for Integrative Medicine in Santa Fe New Mexico, United States, Prof. Osmond Ifeanyi Onyeka, told The Guardian that spirulina contains the most remarkable concentration of nutrients known in any food, plant, grain or herb.

"Spirulina has the highest protein food which is over 60 per cent of all the digestible vegetable protein. Most notably, spirulina is 65 to 71 per cent complete protein, with all essential amino acids in perfect balance. In comparison, beef is only 22 per cent protein. It also has the highest concentration of beta carotene, vitamin B-12, iron and trace minerals and the rare essential fatty acid GLA. These surely make Spirulina an incredible whole food alternative to the isolated vitamin and minerals," Onyeka said.

He added that spirulina is overloaded with unique phyto-nutrients like phycocyanin, polysaccharides and sulphurlipids that not only enhance the immune system, but also reduces the risks of infection, cancer and auto immune diseases.

"Spirulina is rich in natural carotenoid antioxidants that promote cellular health and lessen the risk of cancer. It also has cleansing chlorophyll which helps detoxify bodies that are always prone to present pollution," Onyeka said.

He further explained: "Scientifically explained the most important dictate of our body's metabolism is to support our immune system. When our immune system is stressed or is suffering, it draws on our body's metabolic energy. People with immune system imbalance often feel chronic fatigue and low energy.

"Both scientific research and the experience of thousands of consumers indicate that Spirulina is an immune regulating food. Small amounts can help balance and stabilise the immune system, freeing up more of our metabolic energy for vitality, healing and assimilation of nutrients. It enhances the body's cellular communication process and also has the ability to read and repair DNA, like a kind of cellular tune up. This is why individuals taking Spirulina often report they have more energy levels."

Spirulina is widely available as both an animal and a human dietary supplement in powder, tablet and flake form, and is broadly used due to its nutritional profile. It has been shown to be a complete protein (albeit with lesser amounts of certain amino acids), high in essential fatty acids, vitamins, minerals, photosynthetic pigments including chlorophyll, polysaccharides and glycolipids.

A senior lecturer at the Department of Parasitology and Entomology, Nnamdi Azikiwe University (NAU) Awka, Anambra State, Dr. Abiodun Nwora Ozumba, told The Guardian: "It is unfortunate that the country is sitting on a goldmine and is not doing anything about it. The best spirulina in the whole world grows at our backyard on Lake Chad. It is sold for almost nothing on the streets of Maiduguri. Westerners come here, buy it for little or nothing, go back, develop it into supplements, and ship it back to us to buy.

"Spirulina is 20 times more productive as a protein source than any other food. It could be grown with unused land and water. It was possible to cultivate a pure culture on a large scale in many places around the world. Scientists discovered spirulina was a safe food, had been consumed for hundreds of years by traditional peoples, and showed promising nutritional, and even therapeutic, health benefits.

"If this blue-green algae were cultivated and consumed by millions of people, it would have tremendous benefits, especially for the world's children and our planet's future. Spirulina seemed to be the solution we needed. However, it was all theory, it had not been done yet."

Most cultivated spirulina is produced in open-channel raceway ponds, with paddle-wheels used to agitate the water. The largest commercial producers of spirulina are located in the United States, Thailand, India, Taiwan, China, Pakistan and Myanmar (the Burma).

Phytochemical analysis indicates that spirulina contains an unusually high amount of protein, between 55 per cent and 77 per cent by dry weight, depending upon the source. It is a complete protein, containing all essential amino acids, though with reduced amounts of methionine, cysteine, and lysine when compared to the proteins of meat, eggs, and milk. It is, however, superior to typical plant protein, such as that from legumes.

Spirulina is rich in GLA, and also provides alpha-linolenic acid (ALA), linoleic acid (LA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA).

Spirulina contains vitamin B1 (thiamine), B2 (riboflavin), B3 (nicotinamide), B6 (pyridoxine), B9 (folic acid), vitamin C, vitamin D, and vitamin E.

The bioavailability of vitamin B12 in Spirulina is in dispute. Several biological essays have been used to test for the presence of vitamin B12. The most popular is the United States Pharmacopeia method using the Lactobacillus leichmannii assay. Studies using this method have shown Spirulina to be a minimal source of bioavailable vitamin B12. However, this assay does not differentiate between true B12 (cobalamin) and similar compounds (corrinoids) that cannot be used in human metabolism.

Cyanotech, a grower of spirulina, claims to have done a more recent assay, which has shown spirulina to be a significant source of cobalamin. However, the assay is not published for scientific review and so the validity of this assay is in doubt. The American Dietetic Association and Dietitians of Canada in their position paper on vegetarian diets state that spirulina cannot be counted on as a reliable source of active vitamin B12.

Tests done on Australian grown spirulina by the Australian Government Analytical Laboratory (AGAL) show Vitamin B12 (cobalamin) levels of 659.1 ug / per100g. A one gram tablet could provide more than three times the recommended daily intake of B12.

Previous studies indicate that spirulina is a rich source of potassium, and also contains calcium, chromium, copper, iron, magnesium, manganese, phosphorus, selenium, sodium, and zinc.

Studies also found that spirulina contained many pigments including chlorophyll-a, xanthophyll, beta-carotene, echinenone, myxoxanthophyll, zeaxanthin, canthaxanthin, diatoxanthin, 3'-hydroxyechinenone, beta-cryptoxanthin, oscillaxanthin, plus the phycobiliproteins c-phycocyanin and allophycocyanin.

Despite existing research supporting Spirulina's health and healing properties, detractors claim that these are frequently overstated by Spirulina advocates. Conversely, Spirulina advocates have accused health food detractors of dismissing all such claims without acknowledging this research.

Two online publications exemplify these opposing positions, respectively: Wellness Letter on Blue Green Algae, and Superfoods For Optimum Health: Chlorella and Spirulina. Many positive claims are based on research done on individual nutrients that Spirulina contains, such as GLA, various antioxidants, among others, rather than on direct research using Spirulina. What follows is research on the health and healing effects of Spirulina.

In vitro research (example, studying cells in a petri dish) may suggest the possibility of similar results in humans but, due to the drastically different conditions of the research, provides only hints at the potential for human effects.

Animal research can also provide evidence of potential human effects. Human research focuses on actual effects in humans, however, the validity and reliability of the research depends on the design of the study. The strongest evidence comes from well-designed and controlled clinical trials, which are one type of human research study.

Spirulina extract has been shown to inhibit HIV replication in human T-cells, peripheral blood mononuclear cells (PBMC), and Langerhans cells.

Other studies indicate that spirulina helps prevent heart damage caused by chemotherapy using Doxorubicin, without interfering with its anti-tumor activity. Spirulina reduces the severity of strokes and improves recovery of movement after a stroke; reverses age-related declines in memory and learning; and prevents and treats hay fever.

Spirulina is effective for the clinical improvement of melanosis and keratosis due to chronic arsenic poisoning; improves weight-gain and corrects anemia in both HIV-infected and HIV-negative undernourished children; and protects against hay fever.

A 2007 study found that 36 volunteers taking 4.5 grams of spirulina per day, over a six week period, exhibited significant changes in cholesterol and blood pressure: (1) lowered total cholesterol; (2) increased High Density Lipo-protein (HDL) cholesterol; (3) lowered triglycerides; and (4) lowered systolic and diastolic blood pressure.

However, as this study did not contain a control group, researchers can not be confident that the changes observed are due totally - or even partially - to the effects of the Spirulina Maxima as opposed to other confounding variables (that is, history effects, maturation effects, demand characteristics).

Until recently, much spirulina was certified organic. In 2002, the United States Department of Agriculture's National Organic Standards Board voted to disallow the use of Chilean nitrate. They granted a three-year window to spirulina producers, which expired in 2006. As a result, leading spirulina manufacturers have stopped labelling their spirulina as organic, citing safety concerns of nitrate alternatives.

The United Nations World Food Conference in 1974 lauded Spirulina as the 'best food for the future'. Recognising the inherent potential of Spirulina in the sustainable development agenda, several Member States of the United Nations came together to form an intergovernmental organisation by the name of the Intergovernmental Institution for the Use of Micro-algae Spirulina Against Malnutrition (IMSAM). IIMSAM aspires to build a consensus to make Spirulina a key driver to eradicate malnutrition, achieve food security and bridge the health divide throughout the world.

Spirulina has been proposed by the United States National Aeronautic Space Agency (NASA), and the European Space Agency (EPA); as one of the primary foods to be cultivated during long-term space missions.

Switzer, wrote about his hope for a breakthrough in food production: "It had to be more productive than conventional agriculture... adaptable to different climates and cultures... appropriate ecologically, economically and socially... independent of the vested interests in world food production and distribution... capable of relying on renewable energy and waste or abundant raw material resources. It would have to represent a major expansion of the photosynthetic energy base that supports all life on Earth.

"Finally, it would have to radically improve the supply, distribution and consumption of essential protein to millions of pregnant and nursing mothers, infants and children. It is absolutely critical to provide nutrition to the deprived embryos and infants of the world to preserve the precious creative genius that is waiting to be released from each fully developed human mind."

http://www.ngrguardiannews.com
  more... []

Tuberculosis: HIV Infection Sharply Raises Risk for TB, Report Says
One-quarter of all deaths from tuberculosis are in patients also infected with the AIDS virus, twice as many as previously thought, the World Health Organization said last week.

March 30, 2009

world

One-quarter of all deaths from tuberculosis are in patients also infected with the AIDS virus, twice as many as previously thought, the World Health Organization said last week.

Health Guide: AIDS | Disseminated Tuberculosis

In its annual Global TB Control report, the organization said that being infected with the virus can increase the risk of developing tuberculosis by 20 times.

Up to one-third of the world’s people are infected with tuberculosis bacteria, but the infection usually is dormant unless the immune system is weakened by malnutrition, alcoholism, drug abuse, immunosuppressive drugs, AIDS or other causes.

About 9.3 million people develop TB each year, the report said, and 1.8 million die. About 456,000 are counted as AIDS deaths because the victims have both.

The apparent jump in dual cases is not because of a leap in infections but because African countries are doing a better job of testing patients for both diseases.

Curing a typical tuberculosis infection requires taking four different antibiotics daily for six months. But resistance to those drugs is a growing problem. About 500,000 people now have multi-drug-resistant tuberculosis, which is common in Eastern Europe and in the countries of the former Soviet Union, as well as in China and India. Fewer than 1 percent of them are receiving care that meets W.H.O. standards, which includes daily injections of toxic drugs for two years.

More than 50 countries have reported cases of XDR-TB, the extensively drug-resistant form. Many of those patients die quickly despite treatment.

Doctors Without Borders said after the report’s release that TB was “spiraling out of control.”

By Donald

G. McNeil Jr., http://www.nytimes.com

  more... []

HIV/Hep C Coinfection
1. HIV Before Hep C? Be Careful!
Research indicates that men who acquire hepatitis after HIV infection have worse chances with liver disease.
2. Hepatitis C has no impact on CD4 cell recovery in patients taking HIV treatment
Patients co-infected with HIV and hepatitis C virus whose HIV treatment is suppressing their viral load to undetectable levels have comparable CD4 cell count increases to those seen in patients who are only infected with HIV, investigators report in the April 15th edition of the Journal of Acquired Immune Deficiency Syndromes.

1. HIV Before Hep C? Be Careful!

March 30, 2009

HIV Before Hep C? Be Careful! | HIVPlusMag.com News

At a San Francisco forum titled “Could You Survive HIV Only to Die From Hepatitis C?” presenters talked about the growing number of hepatitis C virus infections found among HIV-positive men who have sex with men.

The Conant Foundation’s Dr. Marcus Conant said outbreaks of hepatitis C apparently linked to sexual activity began appearing among MSM in London and continental European cities around 2002. University of California, San Francisco, researcher Dr. Brad Hare said 42% of HIV-positive men in UCSF’s Positive Health Program now have HCV.

Recent acute HCV coinfections among HIV-positive men appear to represent “a new 21st century clinical syndrome,” said Dr. Daniel Fierer of New York’s Mount Sinai School of Medicine. Previous studies of monogamous HIV-negative heterosexuals indicated a sexual HCV transmission rate of less than 5% -- suggesting sexual transmission is rare. Though specifics vary among studies, the recent acute HCV outbreaks among MSM have been linked to unprotected anal sex, fisting, group sex, sharing sex toys, coinfection with other STDs, and the use of noninjected recreational drugs.

The process whereby HCV destroys the liver typically takes years or decades. But Fierer said his analysis of a small but growing number of coinfected MSM in New York suggests acute HCV infection in a person already infected with HIV leads to unusually rapid liver damage. He has theorized that existing HIV infection may predispose patients to accelerated liver fibrosis if they are subsequently infected with HCV. This rapid disease progression is not common in coinfected injection-drug users, who typically acquire HCV before HIV.

Fierer’s findings are controversial, since U.K. and European researchers have not reported similar rapid disease progression. However, they have tended to use noninvasive methods, not the more accurate liver biopsies employed by Fierer’s team, to evaluate liver damage.

Fierer added the good news that if HCV treatment is begun during the acute phase of infection, there is a good chance of both eliminating HCV and improving liver damage.

http://www.hivplusmag.com


2. Hepatitis C has no impact on CD4 cell recovery in patients taking HIV treatment

March 27, 2009

Patients co-infected with HIV and hepatitis C virus whose HIV treatment is suppressing their viral load to undetectable levels have comparable CD4 cell count increases to those seen in patients who are only infected with HIV, investigators report in the April 15th edition of the Journal of Acquired Immune Deficiency Syndromes.

It is estimated that there are 2 million HIV-positive individuals co-infected with hepatitis C virus in the European region. Earlier research has provided conflicting information on the effect of co-infection on CD4 cell recovery in individuals taking HIV treatment. Differences in adherence to HIV treatment or the potency of antiretroviral regimens were a potential limitation of this studies. Furthermore, they defined hepatitis C-co-infection as the presence of antibodies to the virus and did not investigate the influence of either hepatitis C replication or genotype.

Investigators from the EuroSIDA cohort therefore designed a prospective study to assess the influence of chronic hepatitis C-co-infection and genotype on CD4 cell recovery in HIV-positive patients whose HIV treatment achieved and sustained the suppression of viral load to undetectable levels (below 50 copies/ml).

Patients with antibodies to hepatitis C virus and at least two consecutive undetectable HIV viral loads after starting HIV treatment were eligible for inclusion in the study. The investigators calculated the annual change in CD4 cell count for these patients and then compared them to those observed in patients only infected with HIV whose antiretroviral therapy had suppressed viral load to undetectable. Further analyses were then performed to determine the impact of hepatitis C genotype and replication on CD4 cell recovery.

A total of 4208 patients were included in the investigators’ analyses. The first of these showed that there was no significant difference in the annual CD4 cell count increase seen in the co-infected patients (36 cells/mm3, 95% CI, 27.2-43.9) and the patients only infected with HIV (38 cells/mm3, 95% CI, 34.8-41.9).

These results did not change when the investigators adjusted for hepatitis C genotype. Nor were they altered by adjusting for nucleos(t)ide combinations, third antiretroviral drug, age, time since starting antiretroviral therapy, time to initial viral suppression, or whether an individual was treatment-naïve or treatment experienced when they started combination HIV therapy.

Taking into account ongoing hepatitis C replication did not significantly affect the results. Nor did the hepatitis C genotype influence CD4 cell recovery in these patients with ongoing hepatitis C replication. Finally the investigators compared changes in CD4 cell counts according to co-infected patients’ hepatitis C viral load. This showed that although annual CD4 cell gains (43 cell/mm3) were higher amongst patients with a hepatitis C viral load below 1 million iu/ml than those with a hepatitis C viral load above this level (35 cells/mm3), the difference was not significant (p = 0.43).

“In this large prospective cohort study, we provide evidence that hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients who are persistently maximally HIV suppressed…compared with HIV-monoinfected patients”, write the investigators.

Nor did they find any differences in CD4 cell gain when comparing patients who were hepatitis C “viremic vs. aviremic patients with hepatitis C virus antibodies, and between distinct hepatitis C virus genotypes among viremic patients.”

They do however conclude that co-infected patients may benefit from starting HIV treatment earlier than otherwise recommended “because studies have shown that combination antiretroviral therapy may slow fibrosis progression.” They also note the benefits of hepatitis C treatment for co-infected patients as “hepatitis C virus eradication will lower the risk of hepatotoxicity induced by antiretroviral drugs and progression of liver disease.”

Reference

Peters, L. et al. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression. J Acquir Immune Defic Syndr 50: 457-63, 2009.

By Michael Carter, http://www.aidsmap.com

  more... []

New Drug May Boost HIV Treatment Effectiveness
The addition of an experimental amino acid to a standard HIV drug regimen may be all that’s necessary for people struggling to keep their viral loads undetectable, according to a study published in The Journal of Immunology and reported by EurekAlert.

April 1, 2009

The addition of an experimental amino acid to a standard HIV drug regimen may be all that’s necessary for people struggling to keep their viral loads undetectable, according to a study published in The Journal of Immunology and reported by EurekAlert.

Despite the potency of modern antiretroviral (ARV) treatment, it still fails to keep HIV completely under control in roughly 10 to 20 percent of people beginning treatment for the first time. Researchers have experimented with adding additional ARV drugs to typical regimens, but this strategy—called treatment intensification—comes with a good chance of additional side effects and without a guarantee of increased effectiveness.

Now, Adriano Boasso, PhD, from the Imperial College London, and his colleagues report that a modified amino acid called D-1mT increased the effectiveness of ARV treatment in monkeys infected with simian immunodeficiency virus (SIV)—the monkey version of HIV.

Boasso’s team originally theorized that D-1mT would help control SIV in monkeys regardless of whether they were given ARV treatment. This is because D-1mT is able to block an enzyme called IDO that HIV and SIV use to suppress the immune system’s attempts to control the viruses. Boasso’s team found that D-1mT had no effect at all in monkeys who were not on ARV therapy. To their surprise, however, D-1mT did help four of six monkeys who were on ARV therapy but had uncontrolled virus levels.

“The effect D-1mT seemed to have on viral load was really encouraging, but it was a surprise to us—we didn’t expect D-1mT to work only in [monkeys] that were already being treated with [ARVs],” Boasso said. “It seems that D-1mT synergizes with [ARVs], and we would really like to find out how this works.”

The authors intend to explore this effect further and to evaluate the safety of D-1mT, which is in a Phase I human study as a cancer treatment.

http://www.poz.com
  more... []

Protein Grown in Tobacco Plant Could Result in Low-Cost Microbicide, Study Says
Tobacco has claimed countless lives since people first realized they could chew or smoke it. But researchers have found a use for tobacco that could potentially save lives. A study in Kentucky has shown that a protein found within tobacco plants may be able to inhibit HIV, and that it may be particularly well suited for development in a vaginal microbicide gel. Adding to the protein's appeal is that it apparently can be produced in large amounts cheaply, which may make it especially alluring for use in developing countries.

April 1, 2009

Researchers on Monday announced that tobacco plants in Kentucky have been used in a study to develop a low-cost drug that inhibits HIV, providing hope for the eventual development of a vaginal microbicide, the Louisville Courier-Journal reports (Kenning, Louisville Courier-Journal, 3/31). The study, published Tuesday in the Proceedings of the National Academy of Sciences, was a collaborative effort between scientists at the Owensboro Cancer Research Program; the National Cancer Institute; Kentucky-based biotech companies Intrucept BiomedicineKentucky Bioprocessing; and researchers at Duke University and the University of London (Adkins, Business First of Louisville, 3/30).

According to the Courier-Journal, the researchers used a manufacturing process that utilized an existing protein called Giffithsin, which can inhibit HIV transmission during sexual activity. Kenneth Palmer, lead researcher and senior scientist at the University of Louisville, said that he used a method to grow large amounts of the protein in a relative of the tobacco plant at a low cost, producing 500,000 doses from a 5,000 square-foot greenhouse, the Courier-Journal reports. Palmer said the process resulted in a product that could be more effective than previous microbicide efforts.

According to Palmer, many scientists are pursuing HIV prevention methods, mostly in gel forms that attack the virus, but some have had side effects and were expensive to produce. The Courier-Journal reports that Palmer's product did not appear to cause inflammation in users and that a vaginal gel made through the process "could potentially cost just a few cents." Palmer said that the end-product, likely a gel, could be available as early as 2015 if clinical trials are successful (Louisville Courier-Journal, 3/31). He estimated that "tens of millions" of dollars would be needed to continue the project through the third phase of clinical testing. Donald Miller, director of the James Graham Brown Cancer Center, said that international donors might be interested in assisting in funding the research. Miller said the new study is a "very important piece of work." He added, "We think this is a validation of our belief that this is going to be a very viable, cost-effective way to produce new drugs" (Business First of Louisville, 3/30). According to Palmer, condoms are the only product currently available and "they're obviously not enthusiastically embraced by all users." He added that there is "a big need for an effective, female-controlled intervention to protect from HIV" (Louisville Courier-Journal, 3/31).

www.kaisernetwork.org
  more... []

Earlier Antiretroviral Treatment Could Reduce Risk of Death in HIV-Positive People, Study Finds
For the second analysis, the researchers studied 9,000 patients, comparing those who began treatment six months within receiving a CD4 count of 500 or greater with those who delayed starting treatment until their CD4 count was below 500. The researchers found that there was a 94% higher risk of death among patients who delayed treatment

April 02, 2009

A study published Wednesday in the New England Journal of Medicine suggests that starting HIV-positive people on antiretroviral treatment earlier than what current guidelines recommend could reduce the risk of death, the Wall Street Journal's "Health Blog" reports (Goldstein, "Health Blog," Wall Street Journal, 4/1). Researchers in two separate analyses examined the medical records of about 17,000 HIV-positive people (Waters, Bloomberg, 4/1). They looked at participants' CD4+ T cell count, starting with 8,000 participants in the first analysis. The researchers compared patients who began antiretroviral treatment within six months of receiving a CD4 count between 351 and 500 with those who delayed starting treatment until after their CD4 count was 350 or less. The patients that delayed treatment had a 69% higher risk of death during the follow-up period.

For the second analysis, the researchers studied 9,000 patients, comparing those who began treatment six months within receiving a CD4 count of 500 or greater with those who delayed starting treatment until their CD4 count was below 500. The researchers found that there was a 94% higher risk of death among patients who delayed treatment ("Health Blog," Wall Street Journal, 4/1). Bloomberg reports that the study adds to growing support for changing current guidelines, which recommend starting HIV-positive people on antiretroviral treatment when CD4 counts fall below 350. Current guidelines also say that doctors can decide on an individual basis whether patients with CD4 counts above 350 should begin treatment. For several years, doctors and patients have struggled with when to begin antiretroviral treatment, which can have significant side effects such as nausea, stomach issues, changes in blood fat levels and altered mental processes, Bloomberg reports.

Reaction

The study adds "weight to a growing body of research that suggests treating HIV at earlier stages can help save lives," Bloomberg reports. "The drugs are now safer and the evidence mounting from our data and other data suggests it makes sense to start therapy earlier," Richard Moore, study author and professor of medicine at Johns Hopkins Bloomberg School of Public Health, said. Jason Kantor -- an analyst with RBC Capital Markets in San Francisco -- said the study's findings are already known to many doctors but that they still are likely to spark increased use of antiretroviral treatment. Brad Hare, medical director of the University of California-San Francisco's Positive Health Program at San Francisco General Hospital, said the study provides "a scientific foundation for a practice that a lot of patients and doctors have already been doing, namely starting medications earlier."

Harvard Medical School researchers Paul Sax and Lindsey Baden write in an accompanying editorial that the findings cannot be considered conclusive because researchers did not randomly assign patients to begin treatment at different stages but analyzed patient records, Bloomberg reports. The editorial says, "The supportive evidence for the benefits of earlier therapy continues to increase," although the study did not "provide definitive proof that we should start antiretroviral therapy in all" HIV-positive patients (Bloomberg, 4/1). Sax and Baden also write that the participants who began treatment earlier might have differed from those who waited in ways that improved survival rates and were independent of when they initiated therapy. To address this, researchers should randomly assign patients to begin therapy earlier or later and determine which group fares better, the editorial says, noting that at least three such studies are ongoing or planned ("Health Blog," Wall Street Journal, 4/1). Hare said that the study will spark a discussion into changing current guidelines on when to begin treatment and whether the government should fund a randomized clinical trial. The study was sponsored by two federal agencies, including NIH (Bloomberg, 4/1).

img The study is available online. The accompanying editorial also is available online.

http://www.kaisernetwork.org
  more... []

Resistant HIV Even More Dangerous
Drug-resistant forms of HIV can be spread between individuals who have not received antiretroviral treatment, according to Deenan Pillay of University College, London, and the Health Protection Agency, speaking at the Society for General Microbiology meeting in Harrogate, England.

Resistant HIV Even More Dangerous | HIVPlusMag.com News

Drug-resistant forms of HIV can be spread between individuals who have not received antiretroviral treatment, according to Deenan Pillay of University College, London, and the Health Protection Agency, speaking at the Society for General Microbiology meeting in Harrogate, England.

Antiretroviral therapy is a major advance in the treatment of HIV, and there are currently over 25 drugs available. It is known that the virus can mutate, reducing its susceptibility to treatment, and that these resistant viruses can be transmitted between individuals. Professor Pillay found that drug resistant viruses could also circulate between individuals who have not received antiretroviral drug treatments.

"Our findings show that assuming that drug-resistant HIV was only passed on from individuals receiving drug treatment may mean the number and size of the reservoirs of drug resistant virus…have been underestimated," said Pillay. "Our results indicate that although the incidence of drug resistance has been declining, this might not continue -- which could have implications for planning and management of treatment programs".

http://www.hivplusmag.com
  more... []

LINKS OF INTEREST

Link:  Visit the March 2009 Visual AIDS Web Gallery

Image from the March 2009 Visual AIDS Web Gallery
"Untitled," 1993; Bruce Wm. Witsiepe

Visit the March 2009 Visual AIDS Web Gallery to view our latest collection of art by HIV-positive artists!
This month's gallery, entitled "Liminal:Subliminal: Sublime," is curated by Bernard Leibov.
  more... []

British Columbia Persons With AIDS Society
1107 Seymour Street, 2nd Floor
Vancouver, BC V6B 5S8
Canada
[ Map ]
t. 604.893.2200
1.800.994.2437
f. 604.893.2251
www.bcpwa.org
info@bcpwa.org
Feel free to pass this along to those you feel will be interested.
To have the BCPWA eNews delivered to your inbox, click here [ Subscribe ].
If you no longer wish to receive the BCPWA eNews, click here [ Unsubscribe ].

The HIV / AIDS eNews is brought to you by the BCPWA's Communication Department.
Authorized by the Persons With AIDS Society of BC, registered under the Election Act, 604-893-2200
We value our readers opinions, please send any comment, suggestion or concerns to info@bcpwa.org
Copyright © 2001-2008 BC Persons With AIDS Society. All rights reserved.
Designated trademarks and brands are the property of their respective owners.